Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
793 JPY | -2.46% | -1.00% | -32.34% |
Mar. 21 | US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak | MT |
Mar. 21 | JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion | MT |
Sales 2024 * | 45.37B 292M | Sales 2025 * | 41.75B 268M | Capitalization | 98.97B 636M |
---|---|---|---|---|---|
Net income 2024 * | 7.24B 46.58M | Net income 2025 * | 6.28B 40.39M | EV / Sales 2024 * | 2.46 x |
Net Debt 2024 * | 12.66B 81.38M | Net Debt 2025 * | 9B 57.84M | EV / Sales 2025 * | 2.59 x |
P/E ratio 2024 * |
13.6
x | P/E ratio 2025 * |
15.7
x | Employees | 879 |
Yield 2024 * |
2.47% | Yield 2025 * |
2.52% | Free-Float | 52.97% |
1 day | -2.46% | ||
1 week | -1.00% | ||
Current month | -7.68% | ||
1 month | -11.50% | ||
3 months | -30.92% | ||
6 months | -30.10% | ||
Current year | -32.34% |
Managers | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 45 | 03-03-31 |
Yutaka Honda
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Toshihide Yoda
BRD | Director/Board Member | 61 | 18-06-26 |
Philippe Fauchet
BRD | Director/Board Member | 65 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.67% | 23 M€ | +1.42% | - | |
0.30% | 15 M€ | +5.53% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 793 | -2.46% | 562 900 |
24-04-24 | 813 | +0.62% | 410,000 |
24-04-23 | 808 | -0.37% | 516,800 |
24-04-22 | 811 | +3.84% | 574,400 |
24-04-19 | 781 | -2.25% | 682,500 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.34% | 654M | |
+24.17% | 562B | |
-6.55% | 358B | |
+19.78% | 322B | |
+7.73% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.04% | 149B | |
-6.83% | 146B |
- Stock Market
- Equities
- 4552 Stock